1. |
|
|
2. |
|
|
3. |
- Kressner, U, et al.
(författare)
-
Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer
- 1998
-
Ingår i: BRITISH JOURNAL OF CANCER. - : CHURCHILL LIVINGSTONE. - 0007-0920. ; 77:11, s. 1848-1851
-
Tidskriftsartikel (refereegranskat)abstract
- Serum p53 antibody levels were analysed using an enzyme-linked immunosorbent assay in serum samples obtained before surgery from 184 consecutive patients with primary colorectal cancer. Possible associations with tumour stage and tumour differentiation an
|
|
4. |
|
|
5. |
- Kressner, U, et al.
(författare)
-
Stromal tenascin distribution as a prognostic marker in colorectal cancer
- 1997
-
Ingår i: BRITISH JOURNAL OF CANCER. - : CHURCHILL LIVINGSTONE. - 0007-0920. ; 76:4, s. 526-530
-
Tidskriftsartikel (refereegranskat)abstract
- A total of 169 colorectal adenocarcinomas, obtained from patients with a median follow-up of 6.5 years, were studied with immunohistochemical staining on cryosections using a monoclonal anti-tenascin antibody to evaluate the possible association between t
|
|
6. |
|
|
7. |
|
|
8. |
- Lindmark, G, et al.
(författare)
-
Limited clinical significance of the serum tumour marker CA 72-4 in colorectal cancer
- 1996
-
Ingår i: ANTICANCER RESEARCH. - : INT INST ANTICANCER RESEARCH. - 0250-7005. ; 16:2, s. 895-898
-
Tidskriftsartikel (refereegranskat)abstract
- Background: We explored the potential value of CA 72-4 in the staging and prognostic prediction of colorectal cancer, as compared to six previously investigated serum tumour markers - CEA, Ca 19-9, CA 50, CA 242, TPA, and TPS. Materials and Methods: CA 72
|
|
9. |
|
|
10. |
|
|